Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2018 Q2- Text added to 2018 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
beta, Cheplapharm, clearance, cohort, competitor, conspiracy, durable, excise, Fewer, immunotherapy, Incyte, labeling, lenalidomide, libel, malignant, manner, margin, mesothelioma, misappropriation, MPM, mUC, PDUFA, PI, plaque, pleural, Promedior, proteasome, receptor, reserve, Rigel, satisfaction, secret, Similarly, standalone, stipulated, submission, sued, Territory, TGF, unfavorable, warrant
Removed:
allegedly, CheckMate, coordinate, damage, establish, favorable, Fitch, Jersey, jurisdiction, resident, Supreme, upfront
Valuein 2018 Q2 filing- Value in 2018 Q3 filing
Original filings
Filing view